A similar mechanism is found in the tumour microenvironment in which metabolically active tumour cells deplete nutrients and can significantly lower glucose availability, thereby inhibiting CD4+ Th1 and CD8+ effector T cell function [17]. This evidence concerns the gene CD4 and neoplasm.